Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report. Haemophilia 2013 Mar;19 Suppl 3(0 3):1-18
Date
02/13/2013Pubmed ID
23383607Pubmed Central ID
PMC4164969DOI
10.1111/hae.12078Scopus ID
2-s2.0-84873425397 (requires institutional sign-in at Scopus site) 5 CitationsAbstract
The first meeting of international specialists in the field of von Willebrand disease (VWD) was held in the Åland islands in 1998 where Erik von Willebrand had first observed a bleeding disorder in some members of a family from Föglö and a summary of the meeting was published in 1999. The second meeting was held in 2010 and a report of the meeting was published in 2012. Topics covered included progress in understanding of VWD over the last 50 years; multimers; classification of VWD; pharmacokinetics and laboratory assays; genetics; treating the paediatric patient; prophylaxis; geriatrics; gene therapy and treatment guidelines. This third meeting held over 3 days covered the structure and function of von Willebrand factor (VWF); type 1 VWD, the most common form of the disease; a lifespan of pharmacokinetics in VWD; detecting inhibitors in VWD patients; and special challenges in understanding and treating the female VWD patient.
Author List
Berntorp E, Fuchs B, Makris M, Montgomery R, Flood V, O'Donnell JS, Federici AB, Lillicrap D, James P, Budde U, Morfini M, Petrini P, Austin S, Kannicht C, Jiménez-Yuste V, Lee CAuthor
Veronica H. Flood MD Chief, Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnimalsFactor VIII
Female
Humans
von Willebrand Diseases
von Willebrand Factor
